CYCN
Price
$2.42
Change
-$0.09 (-3.59%)
Updated
Sep 3 closing price
Capitalization
7.77M
GDTC
Price
$1.95
Change
-$0.06 (-2.99%)
Updated
Sep 3 closing price
Capitalization
22.88M
71 days until earnings call
Interact to see
Advertisement

CYCN vs GDTC

Header iconCYCN vs GDTC Comparison
Open Charts CYCN vs GDTCBanner chart's image
Cyclerion Therapeutics
Price$2.42
Change-$0.09 (-3.59%)
Volume$17.03K
Capitalization7.77M
CytoMed Therapeutics
Price$1.95
Change-$0.06 (-2.99%)
Volume$7.3K
Capitalization22.88M
CYCN vs GDTC Comparison Chart in %
Loading...
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCN vs. GDTC commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCN is a Hold and GDTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CYCN: $2.42 vs. GDTC: $1.95)
Brand notoriety: CYCN and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCN: 40% vs. GDTC: 57%
Market capitalization -- CYCN: $7.77M vs. GDTC: $22.88M
CYCN [@Biotechnology] is valued at $7.77M. GDTC’s [@Biotechnology] market capitalization is $22.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCN’s FA Score shows that 1 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • CYCN’s FA Score: 1 green, 4 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, CYCN is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCN’s TA Score shows that 5 TA indicator(s) are bullish while GDTC’s TA Score has 4 bullish TA indicator(s).

  • CYCN’s TA Score: 5 bullish, 4 bearish.
  • GDTC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CYCN is a better buy in the short-term than GDTC.

Price Growth

CYCN (@Biotechnology) experienced а -5.64% price change this week, while GDTC (@Biotechnology) price change was -2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

GDTC is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GDTC($22.9M) has a higher market cap than CYCN($7.77M). CYCN YTD gains are higher at: -24.689 vs. GDTC (-42.647).
CYCNGDTCCYCN / GDTC
Capitalization7.77M22.9M34%
EBITDA-3.76MN/A-
Gain YTD-24.689-42.64758%
P/E RatioN/AN/A-
Revenue2.17MN/A-
Total Cash3.01MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
CYCN: Fundamental Ratings
CYCN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCNGDTC
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 25 days ago
89%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPDN9.012.06
+29.64%
Professional Diversity Network Inc
WOLF1.300.01
+0.78%
Wolfspeed
STNE16.380.10
+0.61%
StoneCo Ltd
SLRC16.55-0.10
-0.60%
SLR Investment Corp
CPRT48.12-0.36
-0.74%
Copart

CYCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCN has been loosely correlated with JANX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCN jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-3.39%
JANX - CYCN
41%
Loosely correlated
+0.79%
HRTX - CYCN
40%
Loosely correlated
+0.76%
GDTC - CYCN
31%
Poorly correlated
-2.74%
ENTO - CYCN
25%
Poorly correlated
+1.09%
CGEN - CYCN
23%
Poorly correlated
-0.70%
More

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-2.74%
CVKD - GDTC
31%
Poorly correlated
+3.71%
CYCN - GDTC
30%
Poorly correlated
-3.39%
ADIL - GDTC
30%
Poorly correlated
-0.72%
QSI - GDTC
27%
Poorly correlated
-0.93%
GRCE - GDTC
27%
Poorly correlated
-0.67%
More